TechnologyNAICS 541511
Sell a HealthTech Software business
Technology M&A shifted decisively toward profitable SaaS, MSPs, and services with recurring revenue after 2023. HealthTech SaaS with HIPAA/HITRUST certifications, payer-or-provider-integrated deployments, and revenue-cycle or clinical-workflow product-market fit trade at premium.
What moves the multiple
Value drivers in healthtech software
Technology businesses sit within a broad multiple band. These are the specific factors that determine where you land inside it.
HealthTech Software-specific
HealthTech SaaS with HIPAA/HITRUST certifications, payer-or-provider-integrated deployments, and revenue-cycle or clinical-workflow product-market fit trade at premium.
Recurring revenue as % of total (>70% for premium multiples)
Net Revenue Retention >100%
Documented, product-led onboarding (not owner-led sales)
Diversified customer base across industry verticals
Modern tech stack and clean codebase
Diligence risks
What buyers scrutinize
Every category has structural risks that buyers double-click on. Preparing responses in advance keeps them out of the purchase-price adjustment column.
HealthTech Software-specific risk
HealthTech sales cycles are notoriously long (12-24 months) and regulatory shifts (interoperability rules, information blocking) create sustained headwinds; buyers scrutinize your sales-velocity and regulatory readiness.
Founder / CTO dependency on product roadmap
Technical debt and legacy platform risk
Concentration in one industry vertical
Cybersecurity + compliance posture (SOC 2, HIPAA when applicable)
Active buyers
Who buys healthtech software businesses
Buyer archetype depends on scale. Sub-$1M SDE draws individuals and search funds. $1–3M SDE opens platform and strategic interest. $3M+ EBITDA is full LMM buyer territory.
Recent acquirer activity
Veradigm (NASDAQ: MDRX), Waystar (NASDAQ: WAY), athenahealth (Bain / Hellman & Friedman), and Insight Partners drive HealthTech consolidation.
Vertical SaaS strategic
StrategicLarger platforms in adjacent verticals buy to add product surface, geo, or industry expertise.
SaaS / MSP PE platform
PE PlatformVista Equity, Thoma Bravo, Hg Capital, Providence Strategic Growth (SaaS); Kaseya, Evergreen, N-able (MSP) actively bid on $2M+ EBITDA operators.
Search fund / independent sponsor
Search FundProfitable, recurring-revenue tech businesses at $1M-$3M EBITDA remain popular search-fund targets.
Playbook
Exit playbook — technology
The single largest driver of purchase-price outcome is preparation depth. These are the levers that move the needle in technology exits.
- 1
Move CEO/CTO off the critical product path 18-24 months before sale
18-24 months pre-saleFounder dependency on the product roadmap is the #1 diligence concern. Formalize a product leadership layer that owns roadmap independently.
- 2
Get to SOC 2 Type II if you have any enterprise customers
12-18 months pre-saleSOC 2 is table stakes for enterprise sales and a hard diligence requirement for PE / strategic buyers. Certification cycles take 9-12 months.
- 3
Instrument NRR + logo retention as first-class metrics
6-12 months pre-saleBuyers pay premium multiples for demonstrable NRR >100%. Track and report by cohort, not just aggregate.
- 4
Address technical debt before diligence
9-12 months pre-saleTechnical due diligence will surface every skeleton. A pre-sale internal tech audit reveals what to address and what to disclose.
Topical cluster
Related industries
Owners of healthtech software businesses often also operate — or acquire — businesses in adjacent verticals.
FAQ
HealthTech Software exits, answered
What is a healthtech software business worth?
Who buys healthtech software businesses right now?
What drives multiple expansion in healthtech software?
What are the biggest risks in selling a healthtech software business?
What revenue range makes healthtech software sellable to a professional buyer?
How long does it take to sell a healthtech software business?
Data provenance: Valuation multiples anchored in SaaS Capital Q4 2024 + Corum M&A Report 2025 + Service Leadership MSP Index. Buyer names and platforms are cited from public M&A disclosures, SEC filings, and press releases. Nothing on this page is fabricated. Multiples are whole-market ranges — your specific business will price above or below based on the drivers and risks above.
Published May 30, 2025 · Updated June 12, 2026
Ready to explore an exit?
Get matched to a healthtech software specialist.
Answer three quick questions. We surface vetted brokers with real healthtech software deal experience.